Transcription of Public Assessment Report Decentralised Procedure ...
{{id}} {{{paragraph}}}
PAR Ursodeoxycholic Acid 300 mg and 500 mg Tablets UK/H/6671/001-002/DC 1 Public Assessment Report Decentralised Procedure Ursodeoxycholic acid 300 mg and 500 mg Tablets (ursodeoxycholic acid) Procedure No: UK/H/6671/001-002/DC UK Licence Number: PL 00289/2169-2170 TEVA UK Limited PAR Ursodeoxycholic Acid 300 mg and 500 mg Tablets UK/H/6671/001-002/DC 2 LAY SUMMARY Ursodeoxycholic acid 300 mg and 500 mg Tablets (ursodeoxycholic acid) This is a summary of the Public Assessment Report (PAR) for Ursodeoxycholic acid 300 mg and 500 mg Tablets (PL 00289/2169-2170; UK/H/6671/001-002/DC). It explains how Ursodeoxycholic acid 300 mg and 500 mg Tablets were assessed and their authorisation recommended, as well as their conditions of use.
PAR Ursodeoxycholic Acid 300 mg and 500 mg Tablets UK/H/6671/001-002/DC 1 Public Assessment Report Decentralised Procedure Ursodeoxycholic acid 300 …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}